Skip to main content
HLB bioStep Co.,Ltd. logo

HLB bioStep Co.,Ltd. — Investor Relations & Filings

Ticker · 278650 ISIN · KR7278650007 KO Professional, scientific and technical activities
Open in API
Filings indexed 326 across all filing types
Latest filing 2024-02-19 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 278650

About HLB bioStep Co.,Ltd.

http://hlbbiostep.com/en/

HLB bioStep Co.,Ltd. is a non-clinical Contract Research Organization (CRO) that provides a range of testing services to pharmaceutical companies and bio ventures. The company's core services support new drug development and include efficacy testing, pharmacokinetic/toxicokinetic (PK/TK) studies, and toxicology evaluations. A key area of specialization is veterinary medicine; HLB bioStep is an institution approved to conduct non-clinical tests and clinical trials for veterinary drugs. It also offers consulting services for regulatory approval procedures. The company utilizes various platform technologies, such as cell-enzyme-based screening and xenograft assays, and provides a comprehensive 'One-Stop Service' that leverages its experience in building laboratory facilities.

Recent filings

Filing Released Lang Actions
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from a Korean company (HLB BioStep) regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. It details the number of shares to be issued, the conversion price, and the remaining balance of the convertible bonds. This type of filing is a standard capital structure update related to equity issuance via debt conversion, which falls under the 'Share Issue/Capital Change' category.
2024-02-19 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea. This type of filing is required when an individual or entity crosses a significant ownership threshold (typically 5%) in a publicly traded company. In the provided taxonomy, this corresponds to 'Major Shareholding Notification' (MRQ).
2024-02-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (disposals) made by an executive/major shareholder (Kim Do Hyung) of HLB Biostep. This type of filing is a standard regulatory requirement for insider trading/shareholding changes by directors and major shareholders, which corresponds to the 'Director's Dealing' category.
2024-02-16 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (HLB Biostep) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement for listed companies in Korea to report preliminary financial results before the final audit is completed. Since it provides key financial highlights and performance metrics rather than a full annual report or a conference call transcript, it falls under the category of an Earnings Release (ER). FY 2023
2024-02-08 Korean
주요사항보고서(자기주식취득신탁계약체결결정)
Transaction in Own Shares Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) from HLB Biostep, specifically detailing a decision to enter into a trust agreement for the acquisition of treasury shares (자기주식취득 신탁계약 체결 결정). This type of filing is a regulatory requirement for companies to disclose share buyback activities, which falls under the 'Transaction in Own Shares' category.
2024-02-08 Korean
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing from HLB Life Science (HLB바이오스텝) regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. This involves the conversion of debt into equity, which results in the issuance of new shares. According to the filing definitions, announcements regarding new share issues or capital changes fall under the 'Share Issue/Capital Change' (SHA) category.
2024-02-07 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.